Article Text

Download PDFPDF
Case report
Intractable pruritus in chronic myelomonocytic leukaemia and myelodysplastic syndromes: a case series
  1. M Mansour Ceesay1,
  2. Tanya N Basu2,
  3. Anthony du Vivier2 and
  4. Ghulam J Mufti1
  1. 1 Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK
  2. 2 Dermatology, King's College Hospital NHS Foundation Trust, London, UK
  1. Correspondence to Dr M Mansour Ceesay; mansour.ceesay{at}nhs.net

Abstract

Intractable pruritus without visible primary skin lesions and refractory to antihistamines as a primary presentation of chronic myelomonocytic leukaemia (CMML) and myelodysplastic syndrome (MDS) is not well recognised. We present two cases of CMML and two cases of MDS with this challenging symptom. In two of them, the pruritus preceded the diagnosis of MDS/CMML by months. Various chemotherapeutic and immunosuppressive options were used with variable success. In one of the cases, the pruritus persisted despite achieving morphological remission of CMML with azacitidine but had a remarkable complete response to cladribine. The pathogenesis of intractable itching in CMML and MDS remains unclear but seems to be linked to the biology of these diseases and could precede definitive diagnostic features. Earlier diagnosis of these myeloid disorders may therefore be aided by increasing awareness among clinicians of the association with pruritus.

  • haematology (incl blood transfusion)
  • dermatology
  • malignant and benign haematology
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors GJM and AdV had the initial concept. MMC, TNB and AdV identified the patients. MMC wrote the manuscript; and TNB and AdV critically the reviewed it.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.